GO:0015132 prostaglandin transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015132 describes the molecular function of moving prostaglandins across biological membranes, a process essential for autocrine and paracrine signaling.
• The prostaglandin transporter PGT (SLCO2A1) is the best-characterized protein mediating prostaglandin reuptake, and its structure reveals a conserved major facilitator superfamily fold.
• PGT-mediated transport regulates ovulation, and its dysfunction is linked to reproductive disorders.
• Prostaglandin transport influences airway surface liquid volume and CFTR activity, with implications for cystic fibrosis [2,4].
• ABCB1 and other ATP-binding cassette transporters can also transport prostaglandins, contributing to drug resistance and reproductive biology.
• CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect the causal roles of prostaglandin transporters in physiology and disease.
Description
Prostaglandins are lipid mediators derived from arachidonic acid that regulate diverse physiological processes, including inflammation, ovulation, and vascular tone. Because they are synthesized on demand and act locally, their signaling is tightly controlled by transport across cell membranes. GO:0015132, prostaglandin transmembrane transporter activity, defines the molecular function responsible for moving prostaglandins from one side of a membrane to the other. This activity is critical for terminating or propagating prostaglandin signals, as it determines the availability of these lipids to their cognate receptors. The prostaglandin transporter PGT (encoded by SLCO2A1) is the prototypical member of this functional class, and its recently solved structure has provided mechanistic insights into substrate recognition and transport. Beyond PGT, other transporters such as members of the ATP-binding cassette (ABC) family can also translocate prostaglandins, expanding the repertoire of proteins that contribute to this GO term. Understanding GO:0015132 is therefore essential for researchers studying lipid signaling, reproductive biology, and inflammatory diseases.
prostaglandin transmembrane transporter activity At A Glance
| GO ID | GO:0015132 |
|---|---|
| GO term | prostaglandin transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | prostaglandin/thromboxane transporter activity |
| Major function | Transfer of prostaglandins across membranes |
| Representative protein | PGT (SLCO2A1), a major facilitator superfamily transporter |
| Related transporters | ABC transporters such as ABCB1 |
| Physiological contexts | Ovulation, airway surface liquid regulation, drug transport [4,6,5] |
What Is GO:0015132?
GO:0015132, prostaglandin transmembrane transporter activity, is a molecular function that enables the transfer of prostaglandins from one side of a membrane to the other. Prostaglandins are biologically active metabolites containing a cyclopentane ring formed by the cyclization of a fatty acid precursor. This transporter activity is also known as prostaglandin/thromboxane transporter activity and is fundamental to the regulation of prostaglandin concentrations in extracellular and intracellular compartments.
Why Is prostaglandin transmembrane transporter activity Important in Cell Biology?
Prostaglandin transmembrane transporter activity is crucial because it controls the spatial and temporal availability of prostaglandins, which are short-lived lipid mediators. By removing prostaglandins from the extracellular space or facilitating their release, transporters shape the intensity and duration of signaling through prostaglandin receptors. This function impacts a wide range of physiological and pathological processes, from ovulation and parturition to inflammation and cancer. Moreover, because prostaglandins are involved in cystic fibrosis airway disease and drug resistance, understanding their transport mechanisms offers potential therapeutic targets [2,4,8].
• Regulates prostaglandin signaling by controlling ligand access to receptors.
• Essential for ovulation, as PGT-mediated transport is required for follicle rupture.
• Modulates airway surface liquid volume and CFTR activity in respiratory epithelium.
• Influences cystic fibrosis pathophysiology through prostaglandin E2 production.
• Contributes to drug transport and resistance in the liver and other tissues.
• Plays a role in reproductive biology via ABC transporters.
• Potential target for anti-inflammatory and pro-fertility therapies.
• Provides a mechanism for autocrine and paracrine regulation of prostaglandin action.
What Happens During prostaglandin transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs the prostaglandin molecule.
Prostaglandin transporters such as PGT recognize specific prostaglandins, including PGE2, PGF2α, and thromboxane, through a binding pocket that accommodates the cyclopentane ring and the carboxylate group. Structural studies of PGT reveal a major facilitator superfamily fold with a central cavity that undergoes conformational changes to accept the substrate. This step is highly selective, ensuring that only prostaglandins and related eicosanoids are transported.
Conformational change and translocation
In simple terms: The transporter changes shape to move the prostaglandin across the membrane.
Upon substrate binding, the transporter undergoes a series of conformational transitions that alternately expose the binding site to opposite sides of the membrane. This alternating-access mechanism is driven by thermal energy and does not require ATP hydrolysis for PGT, which functions as a facilitative transporter. The rate of translocation can be influenced by membrane lipid composition and the electrochemical gradient of the substrate.
Substrate release and resetting
In simple terms: The prostaglandin is released on the other side, and the transporter resets.
After translocation, the prostaglandin is released into the cytoplasm or extracellular milieu, depending on the direction of transport. The transporter then returns to its initial conformation to begin a new cycle. For PGT, this process is reversible and can mediate both uptake and efflux depending on the concentration gradient. The released prostaglandin can then interact with its receptors or be further metabolized.
Regulation by cellular signals
In simple terms: Cellular signals can speed up or slow down the transporter.
Prostaglandin transport activity is regulated by various factors, including protein kinase C, intracellular calcium, and membrane trafficking. For example, in airway epithelial cells, prostaglandin E2 regulation of CFTR activity requires gap junctional communication, suggesting that transport is integrated with intercellular signaling. Additionally, the expression of PGT can be modulated by hormones and inflammatory mediators, affecting overall transport capacity.
Key Genes Involved in GO:0015132 prostaglandin transmembrane transporter activity
The following genes encode proteins that exhibit prostaglandin transmembrane transporter activity or are closely associated with this function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLCO2A1 (PGT) | Primary prostaglandin transporter; mediates uptake and clearance of prostaglandins | Structure-function studies, ovulation, drug transport [3,6] |
| ABCB1 (MDR1) | ABC transporter capable of transporting prostaglandins and drugs | Drug resistance, reproductive biology |
| ABCC4 (MRP4) | Multidrug resistance protein that can transport prostaglandins | Inflammation, cancer |
| CFTR | Chloride channel regulated by prostaglandin signaling; not a transporter itself but functionally linked | Cystic fibrosis, airway surface liquid [2,4] |
| PTGS1 (COX1) | Cyclooxygenase that synthesizes prostaglandins | Prostaglandin synthesis upstream of transport |
| PTGS2 (COX2) | Inducible cyclooxygenase that produces prostaglandins | Inflammation, cancer |
| PLA2G2A | Phospholipase A2 that releases arachidonic acid for prostaglandin synthesis | Cystic fibrosis, inflammation |
| HPGD | 15-hydroxyprostaglandin dehydrogenase, degrades prostaglandins | Prostaglandin catabolism |
| SLCO2B1 | Related organic anion transporter with overlapping substrate specificity | Drug transport, prostaglandin clearance |
| SLCO1B1 | Liver-specific organic anion transporter | Drug transport, prostaglandin handling |
| ABCC1 (MRP1) | Multidrug resistance protein with broad substrate specificity | Drug resistance, prostaglandin efflux |
| ABCG2 (BCRP) | ABC transporter that can transport prostaglandins | Drug resistance, reproductive biology |
| PTGER1-4 | Prostaglandin E2 receptors that mediate signaling after transport | Downstream signaling, inflammation |
| GJA1 (Connexin 43) | Gap junction protein required for prostaglandin-mediated CFTR regulation | Airway surface liquid, cystic fibrosis |
| SLC22A8 (OAT3) | Organic anion transporter that may transport prostaglandins | Drug transport, kidney function |
| SLC22A6 (OAT1) | Organic anion transporter involved in prostaglandin handling | Drug transport, kidney function |
How Is prostaglandin transmembrane transporter activity Regulated?
Prostaglandin transmembrane transporter activity is regulated at multiple levels. Transcriptional regulation of SLCO2A1 (PGT) by hormones and inflammatory cytokines modulates transport capacity. Post-translational modifications, such as phosphorylation by protein kinase C, can alter transporter trafficking and activity. Additionally, the activity of ABC transporters like ABCB1 is regulated by ATP binding and hydrolysis, and their expression is often induced in drug-resistant cells. Membrane lipid composition also influences transporter dynamics, as prostaglandin transport is sensitive to the lipid phase.
prostaglandin transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLCO2A1 | Ovulatory dysfunction, infertility | Knockout mouse, ovarian granulosa cell line |
| CFTR | Cystic fibrosis, airway inflammation | CFBE41o- cells, patient-derived organoids |
| ABCB1 | Multidrug resistance in cancer | Cancer cell lines, xenograft models |
| ABCC4 | Inflammatory diseases, cancer | Knockout mice, macrophage cell lines |
| SLCO1B1 | Drug-induced liver injury | Hepatocyte-like cells, liver organoids |
Reproductive disorders
PGT-mediated prostaglandin transport is essential for ovulation, and reduced PGT activity is associated with ovulatory dysfunction. Studies in mice and humans indicate that PGT expression in the ovary is required for follicle rupture, and its dysregulation may contribute to infertility. Furthermore, ABC transporters in the reproductive tract influence prostaglandin levels, affecting fertility and pregnancy.
Cystic fibrosis and airway disease
In cystic fibrosis, mutations in CFTR lead to altered prostaglandin E2 production and transport. The CFTR DeltaF508 mutation impacts prostaglandin E2 production and type IIA phospholipase A2 expression in pulmonary epithelial cells, suggesting a link between prostaglandin transport and airway inflammation. Additionally, prostaglandin E2 regulation of CFTR activity and airway surface liquid volume requires gap junctional communication, highlighting the importance of transport in maintaining airway hydration.
Cancer and drug resistance
Prostaglandins promote tumor progression, and their transport out of cancer cells can affect the tumor microenvironment. ABC transporters such as ABCB1 and ABCC4 are often overexpressed in drug-resistant cancers and can transport prostaglandins, contributing to chemoresistance. Targeting these transporters may enhance the efficacy of anticancer therapies.
Liver and drug transport
The liver expresses multiple drug transport proteins, including organic anion transporters and ABC transporters, that handle prostaglandins and xenobiotics. Alterations in these transporters can affect drug pharmacokinetics and liver function. Understanding prostaglandin transport in the liver is relevant for drug-induced liver injury and cholestasis.
From prostaglandin transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PGT (SLCO2A1) mediate prostaglandin uptake in vivo? | SLCO2A1 knockout mouse |
| What is the effect of a point mutation in the substrate-binding pocket of PGT? | CRISPR point-mutation knock-in in cell lines |
| Can we visualize PGT trafficking in live cells? | Knock-in of fluorescent tag (e.g., GFP) at the SLCO2A1 locus |
| Does overexpression of ABCB1 increase prostaglandin efflux? | Stable overexpression in HEK293 or cancer cells |
| What is the role of CFTR in prostaglandin-mediated airway surface liquid regulation? | CFTR knockout or DeltaF508 knock-in airway epithelial cells [2,4] |
| How does prostaglandin transport affect ovulation? | Conditional knockout of SLCO2A1 in ovarian granulosa cells |
How to Study the prostaglandin transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled substrate uptake | Transport activity | Quantifying PGT-mediated PGE2 uptake |
| Cryo-EM | Protein structure | Determining PGT conformational states |
| CRISPR knockout | Gene function | Assessing SLCO2A1 role in ovulation |
| Live-cell imaging | Transporter localization and dynamics | Visualizing PGT trafficking |
| ATPase assay | ABC transporter activity | Measuring ABCB1-mediated prostaglandin efflux |
| qPCR/Western blot | Expression levels | Evaluating transporter regulation |
| Gap junction dye transfer | Intercellular communication | Linking prostaglandin transport to CFTR regulation |
Transport assays
Radiolabeled or fluorescent prostaglandin analogs can be used to measure transport activity in cells expressing candidate transporters. For example, uptake of [3H]PGE2 by PGT-expressing cells can be quantified by liquid scintillation counting. Efflux assays using inside-out vesicles or intact cells can assess ABC transporter activity.
Structural biology
Cryo-electron microscopy and X-ray crystallography have been used to solve the structure of PGT, revealing the substrate-binding pocket and conformational changes during transport. These methods provide atomic-level insights into the mechanism of prostaglandin recognition and translocation.
Gene editing and knockout models
CRISPR-Cas9 knockout of SLCO2A1 or ABC transporters in cell lines and animal models allows functional studies of prostaglandin transport in physiology and disease. For instance, SLCO2A1 knockout mice exhibit defective ovulation, demonstrating the importance of PGT in reproduction.
Live-cell imaging
Fluorescently tagged transporters or fluorescent prostaglandin analogs can be used to track transport dynamics in real time. Total internal reflection fluorescence (TIRF) microscopy can visualize transporter trafficking and substrate uptake at the plasma membrane.
How CRISPR Can Be Used to Study GO:0015132 prostaglandin transmembrane transporter activity
Knockout
CRISPR-Cas9 knockout of SLCO2A1 or ABC transporter genes in cell lines and animal models can abolish prostaglandin transport activity, allowing researchers to study the consequences for downstream signaling and physiology. For example, SLCO2A1 knockout mice show impaired ovulation, confirming the essential role of PGT in fertility.
Point Mutation
Introducing point mutations in the substrate-binding pocket or gating residues of PGT can dissect the molecular determinants of substrate specificity and transport mechanism. Such mutations can be generated by CRISPR base editing or homology-directed repair, and their effects assessed by transport assays.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous SLCO2A1 locus enables real-time visualization of transporter localization and trafficking without overexpression artifacts. This approach can reveal how PGT is regulated by cellular signals.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of SLCO2A1 or ABCB1 can increase prostaglandin transport capacity, useful for studying the effects of enhanced transport on cell behavior and drug resistance.
How EDITGENE Supports prostaglandin transmembrane transporter activity Research
Researchers studying prostaglandin transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for prostaglandin transmembrane transporter activity research.
Frequently Asked Questions About prostaglandin transmembrane transporter activity
What is prostaglandin transmembrane transporter activity?
It is a molecular function (GO:0015132) that moves prostaglandins across cell membranes, regulating their signaling.
What genes are involved in prostaglandin transmembrane transporter activity?
Key genes include SLCO2A1 (PGT), ABCB1, ABCC4, and other ABC and SLC transporters [3,8].
How does PGT transport prostaglandins?
PGT uses an alternating-access mechanism to bind and translocate prostaglandins without ATP hydrolysis.
What diseases are linked to prostaglandin transport?
Ovulatory disorders, cystic fibrosis, cancer drug resistance, and liver diseases [2,4,6,8].
Can CRISPR be used to study prostaglandin transporters?
Yes, CRISPR knockout, knock-in, and point mutations enable functional studies of transporter genes.
What is the role of prostaglandin transport in ovulation?
PGT-mediated uptake of prostaglandins is required for follicle rupture and ovulation.
How is prostaglandin transport regulated?
It is regulated by hormones, phosphorylation, and membrane lipid composition [4,6,7].
What methods measure prostaglandin transport activity?
Radiolabeled substrate uptake, ATPase assays, and live-cell imaging [3,8].
Are there drugs that target prostaglandin transporters?
Some NSAIDs and experimental compounds can inhibit prostaglandin transport, but specific inhibitors are under development.
What is the difference between PGT and ABC transporters in prostaglandin transport?
PGT is a facilitative transporter, while ABC transporters use ATP to efflux prostaglandins and other substrates [3,8].
Conclusion
Prostaglandin transmembrane transporter activity (GO:0015132) is a fundamental molecular function that controls the bioavailability of prostaglandins, impacting reproduction, inflammation, and drug resistance. The prototypical transporter PGT (SLCO2A1) has been structurally and functionally characterized, revealing a conserved mechanism of substrate translocation. Dysregulation of this activity contributes to diseases such as ovulatory dysfunction, cystic fibrosis, and cancer [2,4,6,8]. CRISPR-based models are invaluable for dissecting the causal roles of these transporters, and EDITGENE offers tailored services to support such research.
References
- 2. Medjane S et al.. 2005. Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells.. Am J Physiol Lung Cell Mol Physiol 289(5):L816-24 PMID: 15964894
- 3. Zhu Z et al.. 2025. Molecular basis of prostaglandin E(2) reuptake by organic anion transporter PGT.. Nat Commun 17(1):315 PMID: 41326388
- 4. Scheckenbach KE et al.. 2011. Prostaglandin E₂regulation of cystic fibrosis transmembrane conductance regulator activity and airway surface liquid volume requires gap junctional communication.. Am J Respir Cell Mol Biol 44(1):74-82 PMID: 20167933
- 5. Faber KN et al.. 2003. Drug transport proteins in the liver.. Adv Drug Deliv Rev 55(1):107-24 PMID: 12535576
- 6. Yerushalmi GM et al.. 2016. The prostaglandin transporter (PGT) as a potential mediator of ovulation.. Sci Transl Med 8(338):338ra68 PMID: 27169804
- 7. Cribier S et al.. 1993. Dynamics of the membrane lipid phase.. Prostaglandins Leukot Essent Fatty Acids 48(1):27-32 PMID: 8424120
- 8. Bloise E et al.. 2016. ATP-binding cassette transporters in reproduction: a new frontier.. Hum Reprod Update 22(2):164-81 PMID: 26545808
